After Xinlitai, the second biosimilar drug of 5 billion ``dulaglycotide'' starts clinical trial
Amgen acquires Teneobio for US$2.5 billion to consolidate its leading position in new antibody drugs
Discover the real culprit of acute lymphocytic leukemia drug resistance and recurrence-thiopurines
The Food and Drug Administration of Thailand releases the results of food inspections in June 2021
Gastrodin may become a low-toxic and high-efficiency fatty liver treatment drug
New strategy for drug design: Bring copper atoms closer to bacteria
The first Internet management expert guidance on common adverse drug reactions of liver cancer is released
39 drugs will increase in price
Hausen even reported 2 innovative drugs!
National Drug Supervision and Administration Work Video and Telephone Conference Held
100 kinds of special drugs are included in Beijing Puhui Health Insurance, 75 kinds of domestic unapproved indications
carcinoma patients to sorafenib-based drug combination therapy
Notice on matters related to the registration of drug-device combination products
Notice on matters related to the registration of drug-device combination products (No. 52 of 2021)
What kind of innovative tumor drugs do patients need?
Inventory of my country's drug traceability system regulatory policy release overview
"Guidelines for the Management of Comprehensive Clinical Evaluation of Drugs (Trial Version 2021)" Released
The State Food and Drug Administration issued a notice on timely submission of the original and auxiliary package annual report
The adjustment of the national medical insurance drug catalogue starts in 2021
How should companies that develop "exclusive" companion diagnostic genetic testing for innovative drugs deal with the challenges?